Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Director | January 23, 2024 | January 25, 2024 |
| Catalent, Inc.CTLT · Entity 16279 | SVP & Chief Financial Officer | February 16, 2021 | February 18, 2021 |
| Zoetis Inc.ZTS · Entity 679 | Chief Financial Officer | July 10, 2026 | July 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date January 23, 2024 · Filed January 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,834 |
Reported balance
After 2024-01-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-01-23 · Grant · Acquired 1,897 · Balance 5,834 F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2: Grant of stock-settled Restricted Stock Units granted under the Ashland Inc. Omnibus Incentive Plan. The Restricted Stock Units are deferred at the election of the Reporting Person under the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors until retirement from service as a director. The Restricted Stock Units will vest one year after the grant date. One (1) Restricted Stock Unit in the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock. F3: Balance includes additional Restricted Stock Units acquired in lieu of cash dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.
F2: Grant of stock-settled Restricted Stock Units granted under the Ashland Inc. Omnibus Incentive Plan. The Restricted Stock Units are deferred at the election of the Reporting Person under the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors until retirement from service as a director. The Restricted Stock Units will vest one year after the grant date. One (1) Restricted Stock Unit in the Ashland Inc. Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.
F3: Balance includes additional Restricted Stock Units acquired in lieu of cash dividends.
Catalent, Inc.
Report date February 16, 2021 · Filed February 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,823 |
Last balance in matching sequence
After 2021-02-16 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2021-02-16 · Exercise / conversion · Acquired 1,076 · Balance 50,899 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2: Includes restricted stock units. Row 2 · 2021-02-16 · Exercise / conversion · Acquired 3,924 · Balance 54,823 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2: Includes restricted stock units. Row 3 · 2021-02-16 · Sale · Disposed 1,799 · Balance 53,024 F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F4: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes restricted stock units. Row 4 · 2021-02-16 · Sale · Disposed 1,200 · Balance 51,824 F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F5: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes restricted stock units. Row 5 · 2021-02-16 · Sale · Disposed 1,001 · Balance 50,823 F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F6: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes restricted stock units. Row 6 · 2021-02-16 · Sale · Disposed 1,000 · Balance 49,823 F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F7: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes restricted stock units. |
| Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $43.88 · Expires 2028-07-23 | Direct | 17,631 |
Reported balance
After 2021-02-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-02-16 · Exercise / conversion · Disposed 1,076 · Balance 17,631 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F8: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. |
| Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $54.94 · Expires 2029-07-22 | Direct | 11,773 |
Reported balance
After 2021-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-02-16 · Exercise / conversion · Disposed 3,924 · Balance 11,773 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F9: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
F2: Includes restricted stock units.
F3: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
F4: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.
F9: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
Zoetis Inc.
Report date July 10, 2026 · Filed July 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitSEC Table II · derivative / convertible security | Direct | 10,155.3554 |
Reported balance
After 2026-07-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-10 · Grant · Acquired 363.0526 · Balance 10,155.3554 F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. |
Filing footnotes · ownership attribution and instrument terms
F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2023 Filed Apr 10, 2023 20:31 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 302.4176 | $53.59 | $16,206.56 |
DisclosureSEC source: 0001555280-23-000132 · wf-form4_168115869364208.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,747.0382 Underlying: Common Stock · 95.9309 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 491.9788 | $52.84 | $25,996.16 |
DisclosureSEC source: 0001555280-23-000120 · wf-form4_168064286566092.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,444.6206 Underlying: Common Stock · 156.1894 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:27 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 15,208 | $0.00 Strike: $162.07 | $0.00 |
DisclosureSEC source: 0001555280-23-000056 · wf-form4_167607164008722.xml · derivative · entry 3 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,208 Underlying: Common Stock · 15,208 shares Expires not disclosed F8 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. F9 · derivative.exercise_date: One-third of each option will vest on the first, second and third anniversaries of the date of grant. F10 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:27 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 4,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-23-000056 · wf-form4_167607164008722.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,087 Underlying: Common Stock · 4,087 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 22:36 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,365 | $109.85 | $149,945.25 |
DisclosureSEC source: 0001127602-23-002342 · form4.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,872 Underlying: Common Stock · 1,365 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and deferred at the election of the reporting person under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022 until retirement from service as a director. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F2 · derivative.expiration_date: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and deferred at the election of the reporting person under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022 until retirement from service as a director. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F3 · balance_after: Balance includes 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 8 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 7 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022, Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:30 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 158.3097 | $51.02 | $8,076.96 |
DisclosureSEC source: 0001555280-23-000018 · wf-form4_167407743295645.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952.6418 Underlying: Common Stock · 302.037 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:36 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 201.521 | $46.76 | $9,423.12 |
DisclosureSEC source: 0001555280-22-000250 · wf-form4_166552053733662.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794.3321 Underlying: Common Stock · 252.0389 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:17 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 172.0175 | $54.78 | $9,423.12 |
DisclosureSEC source: 0001555280-22-000214 · wf-form4_165826541760213.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592.8111 Underlying: Common Stock · 186.0559 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 08, 2022 Filed Apr 13, 2022 00:09 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 263.7277 | $62.20 | $16,403.86 |
DisclosureSEC source: 0001555280-22-000157 · wf-form4_164980852223077.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420.7936 Underlying: Common Stock · 130.8079 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 91.4276 | $59.61 | $5,450.00 |
DisclosureSEC source: 0001555280-22-000138 · wf-form4_164885088081475.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157.0659 Underlying: Common Stock · 28.4863 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 11,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,243 Underlying: Common Stock · 11,243 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 11,243 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:37 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 2,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000054 · wf-form4_164453620455599.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,332.3751 Underlying: Common Stock · 2,856 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 27,476.3751 RSUs will vest on June 30, 2024; and 2,856 RSUs will vest on February 8, 2025. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 22:00 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,139 | $96.61 | $110,038.79 |
DisclosureSEC source: 0001127602-22-002072 · form4.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,474 Underlying: Common Stock · 1,139 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2021; 4 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2021. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 22:10 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 65.6383 | $63.87 | $4,192.32 |
DisclosureSEC source: 0001555280-22-000019 · wf-form4_164263020650620.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65.6383 Underlying: Common Stock · 20.3333 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:28 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 7,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,366 Underlying: Common Stock · 7,512 shares Expires not disclosed F5 · security: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F6 · derivative.exercise_date: Each vested restricted stock unit will be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:28 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 19,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,854 Underlying: Common Stock · 19,854 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each restricted stock unit will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F1 · balance_after: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 3,924 | $0.00 Strike: $54.94 | $0.00 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · derivative · entry 8 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,773 Underlying: Common Stock · 3,924 shares Expires 2029-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F9 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 1,076 | $0.00 Strike: $43.88 | $0.00 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · derivative · entry 7 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,631 Underlying: Common Stock · 1,076 shares Expires 2028-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F8 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 1,000 | $127.00 | $127,000.00 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 6 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,823 F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F7 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.87 to $127.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 1,001 | $126.13 | $126,256.13 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 5 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,823 F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F6 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $125.82 to $126.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 1,200 | $123.73 | $148,476.00 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 4 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,824 F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F5 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $123.46 to $124.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 1,799 | $122.82 | $220,953.18 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 3 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,024 F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F4 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $122.46 to $123.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 3,924 | $54.94 | $215,584.56 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 1,076 | $43.88 | $47,214.88 |
DisclosureSEC source: 0001596783-21-000042 · wf-form4_161366015633591.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 14:05 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 4,604 | $113.73 | $523,612.92 |
DisclosureSEC source: 0001596783-21-000040 · wf-form4_161296589334844.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,823 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $113.63 to $113.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 22:16 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002834 · form4.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319 Underlying: Common Stock · 1,319 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 02:46 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 172 | $104.42 | $17,960.24 |
DisclosureSEC source: 0001596783-21-000018 · wf-form4_160990115198860.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,427 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $104.27 to $104.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:24 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 179 | $87.71 | $15,700.09 |
DisclosureSEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 4 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,599 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:24 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 3 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,778 F3 · kind: Shares received by the reporting person under the issuer's long-term incentive plan in respect of the fiscal 2017-19 performance period that correct the original vested amount received on August 22, 2019. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:24 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 3,301 | $87.71 | $289,530.71 |
DisclosureSEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,415 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:24 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 9,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000172 · wf-form4_159890903274377.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,716 F1 · kind: Received upon the achievement of the fiscal 2018-20 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 16:01 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 11,700 | $0.00 Strike: $88.10 | $0.00 |
DisclosureSEC source: 0001596783-20-000117 · wf-form4_159647049735556.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Underlying: Common Stock · 11,700 shares Expires 2030-07-30 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 30, 2021. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 16:01 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000117 · wf-form4_159647049735556.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,172 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 12:11 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 761 | $81.64 | $62,128.04 |
DisclosureSEC source: 0001596783-20-000081 · wf-form4_159593828162784.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,015 F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 16:20 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 349 | $56.46 | $19,704.54 |
DisclosureSEC source: 0001596783-20-000041 · wf-form4_158679483988706.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,776 F1 · shares: Restricted stock units (RSUs) received in lieu of reporting person's receipt of certain other compensation. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on December 31, 2020. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:48 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 4,176 | $55.24 | $230,682.24 |
DisclosureSEC source: 0001596783-19-000160 · wf-form4_156684891234566.xml · nonDerivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:48 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 11,261 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000160 · wf-form4_156684891234566.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,603 F1 · kind: Received upon the achievement of the fiscal 2017-19 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 20:21 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 954 | $57.26 | $54,626.04 |
DisclosureSEC source: 0001596783-19-000103 · wf-form4_156451807113155.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,342 F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 22, 2019 Filed Jul 25, 2019 00:53 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 15,697 | $0.00 Strike: $54.94 | $0.00 |
DisclosureSEC source: 0001596783-19-000080 · wf-form4_156401598974235.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,697 Underlying: Common Stock · 15,697 shares Expires 2029-07-22 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. Read SEC document |
| July 22, 2019 Filed Jul 25, 2019 00:53 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000080 · wf-form4_156401598974235.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,296 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 28, 2019 Filed May 30, 2019 22:54 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 9,453 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · derivative · entry 3 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,453 shares Expires 2019-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercised in contemplation of upcoming expiration. Read SEC document |
| May 28, 2019 Filed May 30, 2019 22:54 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 4,677 | $46.23 | $216,217.71 |
DisclosureSEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · nonDerivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,383 F2 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 28, 2019 Filed May 30, 2019 22:54 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 9,453 | $10.71 | $101,241.63 |
DisclosureSEC source: 0001596783-19-000051 · wf-form4_155925684787126.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 15, 2018 Filed Oct 16, 2018 19:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 303 | $41.47 | $12,565.41 |
DisclosureSEC source: 0001596783-18-000154 · wf-form4_153971970886381.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,607 F1 · shares: Represents shares withheld to pay the applicable withholding taxes associated with the vesting of certain restricted stock units granted by the Issuer to the reporting person pursuant to the Issuer's 2014 Omnibus Incentive Plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 20:49 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 502 | $43.66 | $21,917.32 |
DisclosureSEC source: 0001596783-18-000118 · wf-form4_153557578299218.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,914 F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2018 Filed Sep 4, 2018 23:51 UTC Amendment | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 502 | $43.66 | $21,917.32 |
DisclosureSEC source: 0001596783-18-000138 · wf-form4a_153610509689856.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,910 F1 · acquired: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction. F1 · balance_after: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:23 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 1,835 | $41.83 | $76,758.05 |
DisclosureSEC source: 0001596783-18-000094 · wf-form4_153540498458858.xml · nonDerivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,412 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:23 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000094 · wf-form4_153540498458858.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,247 F1 · kind: Received upon the achievement of the fiscal 2016-18 performance-based vesting criteria set forth in certain performance share units held by the reporting person. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 17:46 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 18,707 | $0.00 Strike: $43.88 | $0.00 |
DisclosureSEC source: 0001596783-18-000048 · wf-form4_153254073781311.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,707 Underlying: Common Stock · 18,707 shares Expires 2028-07-23 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 17:46 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000048 · wf-form4_153254073781311.xml · nonDerivative · entry 1 Joseph Wetteny · CIK 0001285781 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,898 F1 · shares: Restricted stock received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Subject to forfeiture until vested on third anniversary of grant. F2 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.